Ace Therapeutics is a preclinical CRO specializing in the development of digestive system disease models. Our services empower researchers to advance their understanding of disease mechanisms and evaluate potential therapeutics, accelerating progress in digestive system research.

Ace Therapeutics employs a multidisciplinary approach to offer customized platforms that propel food allergy research forward. Our services encompass the generation of intestinal organoids and microfluidic gut chips, replicating epithelial-immune-microbiota interactions. Additionally, we provide allergen sensitization, oral challenge, and genetically engineered mouse models, enabling comprehensive investigations into food allergy mechanisms and interventions.

Learn more: Digestive Disease Model Customization Services